Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

News releases from Passage Bio

< Previous 1 2 Next >
Passage Bio Receives European Commission Orphan Designation for PBKR03 for Treatment of Krabbe Disease
Tickers PASG
From GlobeNewswire News Releases
Passage Bio Announces First Patient Dosed in Imagine-1 Study of PBGM01 Gene Therapy for Infantile GM1 Gangliosidosis
Tickers PASG
From GlobeNewswire News Releases
Passage Bio to Participate in Upcoming April Investor Conferences
Tickers PASG
From GlobeNewswire News Releases
Passage Bio Appoints Eliseo O. Salinas, M.D., MSc, as Chief Research & Development Officer
Tickers PASG
From GlobeNewswire News Releases
U.S. Food and Drug Administration Grants Fast Track Designation to Three Passage Bio Gene Therapy Candidates Targeting Rare CNS Disorders
FDA designation will facilitate development and expedited review of company’s lead gene therapy product candidates for life-threatening diseases with unmet medical needs: PBGM01 for GM1 gangliosidosis... 
Tickers PASG
From GlobeNewswire News Releases
Passage Bio Reports Fourth Quarter and Full-Year 2020 Financial Results and Recent Business Highlights
Tickers PASG
From GlobeNewswire News Releases
Passage Bio to Participate in Upcoming March Investor Conferences
Tickers PASG
From GlobeNewswire News Releases
Passage Bio to Report Fourth Quarter and Full-Year 2020 Financial Results on March 3, 2021
Tickers PASG
From GlobeNewswire News Releases
Passage Bio Appoints Maxine Gowen, Ph.D. to Board of Directors
Tickers PASG
From GlobeNewswire News Releases
FDA Clears IND Application for Passage Bio’s Gene Therapy Candidate PBKR03 for Treatment of Patients with Early Infantile Krabbe Disease, A Rare Pediatric Disorder with No Approved Disease-Modifying T
Tickers PASG
From GlobeNewswire News Releases
Passage Bio Receives FDA Clearance of IND Application for PBFT02 Gene Therapy Candidate for Treatment of Patients with Frontotemporal Dementia with Granulin Mutations
Tickers PASG
From GlobeNewswire News Releases
Passage Bio Announces Pricing of Public Offering
Tickers PASG
From GlobeNewswire News Releases
Passage Bio Announces Launch of Proposed Public Offering
Tickers PASG
From GlobeNewswire News Releases
Passage Bio to Host First of a Series of 2021 Virtual R&D Events on January 25
Tickers PASG
From GlobeNewswire News Releases
Passage Bio Announces Plan to Deliver on Multiple Meaningful Catalysts in 2021
Tickers PASG
From GlobeNewswire News Releases
Passage Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference
Tickers PASG
From GlobeNewswire News Releases
Passage Bio Receives FDA Clearance of IND Application for Lead Gene Therapy Candidate PBGM01 for Treatment of Infantile GM1 Gangliosidosis
Tickers PASG
From GlobeNewswire News Releases
Passage Bio Announces Gene Therapy Manufacturing Research and Development Site
Tickers PASG
From GlobeNewswire News Releases
Passage Bio Receives MHRA Clinical Trial Authorization for PBGM01 for Treatment of GM1 Gangliosidosis
Tickers PASG
From GlobeNewswire News Releases
Passage Bio Teams with Catalent to Start CGMP Manufacturing for Lead Gene Therapy Products
- Completion of dedicated CGMP suite enhances manufacturing readiness and secures supply chain control to support lead CNS gene therapy product candidates as they advance through clinical trials to... 
Tickers PASG
From GlobeNewswire News Releases
Passage Bio to Present at Piper Sandler 32nd Annual Healthcare Conference
Tickers PASG
From GlobeNewswire News Releases
Passage Bio Highlights University of Pennsylvania’s Gene Therapy Program’s Newly Published Research to Prevent Toxicity Associated with Gene Therapy
Through its unique collaboration agreement, Passage Bio has certain rights to technology highlighted in the University’s research, which has the potential to significantly advance nascent field of gene... 
Tickers PASG
From GlobeNewswire News Releases
Passage Bio to Participate in Upcoming November Investor Conferences
Tickers PASG
From GlobeNewswire News Releases
Passage Bio Reports Third Quarter 2020 Financial Results and Recent Business Highlights
Tickers PASG
From GlobeNewswire News Releases
Passage Bio to Report Third Quarter 2020 Financial Results on November 10, 2020
Tickers PASG
From GlobeNewswire News Releases
Passage Bio’s PBKR03 Receives Orphan Drug and Rare Pediatric Disease Designations from FDA for Treatment of Krabbe Disease
Tickers PASG
From GlobeNewswire News Releases
Passage Bio’s PBGM01 Receives Orphan Drug Designation from EMA for Treatment of GM1 Gangliosidosis
Tickers PASG
From GlobeNewswire News Releases
Passage Bio Announces Publication of Preclinical Data That Show Single Injection of Optimized AAV Vector into Cerebral Spinal Fluid Corrects Neurological Disease, Supporting Advancement of PBGM01 into
The study conducted by the University of Pennsylvania’s Gene Therapy Program supports the potential of Passage Bio’s PBGM01 to correct the underlying genetic defect of GM1 gangliosidosis, a rare,... 
Tickers PASG
From GlobeNewswire News Releases
Passage Bio to Participate in 2020 Virtual Cell & Gene Meeting on the Mesa
Tickers PASG
From GlobeNewswire News Releases
Passage Bio to Participate in Upcoming October Investor Conferences
Tickers PASG
From GlobeNewswire News Releases
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.